Ashar Bhavesh 4
4 · SpringWorks Therapeutics, Inc. · Filed Jan 14, 2025
Insider Transaction Report
Form 4
Ashar Bhavesh
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-01-10+17,323→ 63,069 total - Award
Stock Option (Right to Buy)
2025-01-10+50,615→ 50,615 totalExercise: $43.00Exp: 2035-01-10→ Common Stock (50,615 underlying)
Footnotes (2)
- [F1]This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty-three percent (33%) to vest on January 10, 2026, another thirty-three percent (33%) to vest on January 10, 2027 and the remaining thirty-four percent (34%) to vest on January 10, 2028, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
- [F2]This option shall vest in forty-eight (48) equal monthly installments following January 10, 2025, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.